Back to 
CITADEL ADVISORS LLC
CITADEL ADVISORS LLC
CUE1 quarters
Position history for CITADEL ADVISORS LLC's holdings in CUE BIOPHARMA INC
CITADEL ADVISORS LLC holds 25,633 shares of CUE (CUE BIOPHARMA INC), worth $808,977 as of 2026-Q2. This is a new position. CUE represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$808,977
Current Shares
25,633
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CUE: DRIEHAUS CAPITAL MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG